|
1
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar
|
|
2
|
Kang X, Chen K, Li Y, Li J, D'Amico TA and
Chen X: Personalized targeted therapy for esophageal squamous cell
carcinoma. World J Gastroenterol. 21:7648–7658. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2019. CA Cancer J Clin. 68:7–30. 2019. View Article : Google Scholar
|
|
4
|
Abnet CC, Arnold M and Wei WQ:
Epidemiology of esophageal squamous cell carcinoma.
Gastroenterology. 154:360–373. 2018. View Article : Google Scholar :
|
|
5
|
Wang C, Wang J, Chen Z, Gao Y and He J:
Immunohistochemical prognostic markers of esophageal squamous cell
carcinoma: A systematic review. Chin J Cancer. 36:652017.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Li J, Qi Z, Hu YP and Wang YX: Possible
biomarkers for predicting lymph node metastasis of esophageal
squamous cell carcinoma: A review. J Int Med Res. 47:544–556. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Salehi S, Taheri MN, Azarpira N, Zare A
and Behzad-Behbahani A1: State of the art technologies to explore
long non-coding RNAs in cancer. J Cell Mol Med. 21:3120–3140. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Li X, Wu Z, Fu X and Han W: lncRNAs:
Insights into their function and mechanics in underlying disorders.
Mutat Res Rev Mutat Res. 762:1–21. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Forrest ME and Khalil AM: Review:
Regulation of the cancer epigenome by long non-coding RNAs. Cancer
Lett. 407:106–112. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Flockhart RJ, Webster DE, Qu K,
Mascarenhas N, Kovalski J, Kretz M and Khavari PA: BRAFV600E
remodels the melanocyte transcriptome and induces BANCR to regulate
melanoma cell migration. Genome Res. 22:1006–1014. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang Y, Lin X, Fu X, Yan W, Lin F, Kuang
P, Luo Y, Lin E, Hong X and Wu G: Long non-coding RNA BANCR
regulates cancer stem cell markers in papillary thyroid cancer via
the RAF/MEK/ERK signaling pathway. Oncol Rep. 40:859–866.
2018.PubMed/NCBI
|
|
12
|
Shen X, Bai Y, Luo B and Zhou X:
Upregulation of lncRNA BANCR associated with the lymph node
metastasis and poor prognosis in colorectal cancer. Biol Res.
50:322017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhou T and Gao Y: Increased expression of
lncRNA BANCR and its prognostic significance in human
hepatocellular carcinoma. World J Surg Oncol. 14:82016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liu Z, Yang T, Xu Z and Cao X:
Upregulation of the long non-coding RNA BANCR correlates with tumor
progression and poor prognosis in esophageal squamous cell
carcinoma. Biomed Pharmacother. 82:406–412. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chen Q, Zheng Y, Wu B, Chen X, Sun F, Ge P
and Wang P: BANCR regulates the cell invasion and migration in
esophageal squamous cell carcinoma through Wnt/β-catenin signaling
pathway. Onco Targets Ther. 12:9319–9327. 2019. View Article : Google Scholar :
|
|
16
|
Anfossi S, Fu X, Nagvekar R and Calin GA:
MicroRNAs, regulatory messengers inside and outside cancer cells.
Adv Exp Med Biol. 1056:87–108. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Abba ML, Patil N, Leupold JH, Moniuszko M,
Utikal J, Niklinski J and Allgayer H: MicroRNAs as novel targets
and tools in cancer therapy. Cancer Lett. 387:84–94. 2017.
View Article : Google Scholar
|
|
18
|
Li Z, Wu X, Gu L, Shen Q, Luo W, Deng C,
Zhou Q, Chen X, Li Y, Lim Z, et al: Long non-coding RNA ATB
promotes malignancy of esophageal squamous cell carcinoma by
regulating miR-200b/Kindlin-2 axis. Cell Death Dis. 8:e28882017.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Liu H, Deng H, Zhao Y, Li C and Liang Y:
lncRNA XIST/miR-34a axis modulates the cell proliferation and tumor
growth of thyroid cancer through MET-PI3K-AKT signaling. J Exp Clin
Cancer Res. 37:2792018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang L, Wei Z, Wu K, Dai W, Zhang C, Peng
J and He Y: Long noncoding RNA B3GALT5-AS1 suppresses colon cancer
liver metastasis via repressing microRNA-203. Aging (Albany NY).
10:3662–3682. 2018. View Article : Google Scholar
|
|
21
|
Zhang R, Shi H, Ren F, Liu Z, Ji P, Zhang
W and Wang W: Down-regulation of miR-338-3p and Up-regulation of
MACC1 indicated poor prognosis of epithelial ovarian cancer
patients. J Cancer. 10:1385–1392. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhang Y, Zhang D, Lv J, Wang S and Zhang
Q: lncRNA SNHG15 acts as an oncogene in prostate cancer by
regulating miR-338-3p/FKBP1A axis. Gene. 705:44–50. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Luan X and Wang Y: lncRNA XLOC_006390
facilitates cervical cancer tumorigenesis and metastasis as a ceRNA
against miR-331-3p and miR-338-3p. J Gynecol Oncol. 29:e952018.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Li X, Li Z, Yang G and Pan Z:
MicroRNA-338-3p suppresses tumor growth of esophageal squamous cell
carcinoma in vitro and in vivo. Mol Med Rep. 12:3951–3957. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sharmila G, Bhat FA, Arunkumar R, Elumalai
P, Raja Singh P, Senthilkumar K and Arunakaran J: Chemopreventive
effect of quercetin, a natural dietary flavonoid on prostate cancer
in in vivo model. Clin Nutr. 33:718–726. 2014. View Article : Google Scholar
|
|
26
|
Ma W, Zhang T, Pan J, Shi N, Fan Q, Wang L
and Lu SH: Assessment of insulin-like growth factor 1 receptor as
an oncogene in esophageal squamous cell carcinoma and its potential
implication in chemotherapy. Oncol Rep. 32:1601–1609. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kong KL, Kwong DL, Chan TH, Law SY, Chen
L, Li Y, Qin YR and Guan XY: MicroRNA-375 inhibits tumour growth
and metastasis in oesophageal squamous cell carcinoma through
repressing insulin-like growth factor 1 receptor. Gut. 61:33–42.
2012. View Article : Google Scholar
|
|
28
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
29
|
Li Y, Chen D, Gao X, Li X and Shi G:
lncRNA NEAT1 regulates cell viability and invasion in esophageal
squamous cell carcinoma through the miR-129/CTBP2 axis. Dis
Markers. 2017:53146492017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Chen M, Liu P, Chen Y, Chen Z, Shen M, Liu
X, Li X, Li A, Lin Y, Yang R, et al: Long noncoding RNA FAM201A
mediates the radiosensitivity of esophageal squamous cell cancer by
regulating ATM and mTOR expression via miR-101. Front Genet.
9:6112018. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chang ZW, Jia YX, Zhang WJ, Song LJ, Gao
M, Li MJ, Zhao RH, Li J, Zhong YL, Sun QZ, et al:
lncRNA-TUSC7/miR-224 affected chemotherapy resistance of esophageal
squamous cell carcinoma by competitively regulating DESC1. J Exp
Clin Cancer Res. 37:562018. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wu Y, Hu L, Liang Y, Li J, Wang K, Chen X,
Meng H, Guan X, Yang K and Bai Y: Up-regulation of lncRNA CASC9
promotes esophageal squamous cell carcinoma growth by negatively
regulating PDCD4 expression through EZH2. Mol Cancer. 16:1502017.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Mei LL, Qiu YT, Huang MB, Wang WJ, Bai J
and Shi ZZ: miR-99a suppresses proliferation, migration and
invasion of esophageal squamous cell carcinoma cells through
inhibiting the IGF1R signaling pathway. Cancer Biomark. 20:527–537.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ke K, Sun Z and Wang Z: Downregulation of
long non-coding RNA GAS5 promotes cell proliferation, migration and
invasion in esophageal squamous cell carcinoma. Oncol Lett.
16:1801–1808. 2018.PubMed/NCBI
|
|
35
|
Zhang Q, Zhao X, Zhang C, Wang W, Li F,
Liu D, Wu K, Zhu D, Liu S, Shen C, et al: Overexpressed PKMYT1
promotes tumor progression and associates with poor survival in
esophageal squamous cell carcinoma. Cancer Manag Res. 11:7813–7824.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Bertrand FE, Steelman LS, Chappell WH,
Abrams SL, Shelton JG, White ER, Ludwig DL and McCubrey JA: Synergy
between an IGF-1R antibody and Raf/MEK/ERK and PI3K/Akt/mTOR
pathway inhibitors in suppressing IGF-1R-mediated growth in
hematopoietic cells. Leukemia. 20:1254–1260. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Guo L, Bai Y, Ji S and Ma H: MicroRNA98
suppresses cell growth and invasion of retinoblastoma via targeting
the IGF1R/k-Ras/Raf/MEK/ERK signaling pathway. Int J Oncol.
54:807–820. 2019.PubMed/NCBI
|
|
38
|
Sundaram GM and Veera Bramhachari P:
Molecular interplay of pro-inflammatory transcription factors and
non-coding RNAs in esophageal squamous cell carcinoma. Tumour Biol.
39:10104283177057602017. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Tan D, Wu Y, Hu L, He P, Xiong G, Bai Y
and Yang K: Long noncoding RNA H19 is up-regulated in esophageal
squamous cell carcinoma and promotes cell proliferation and
metastasis. Dis Esophagus. 30:1–9. 2017.
|
|
40
|
Bao J, Zhou C, Zhang J, Mo J, Ye Q, He J
and Diao J: Upregulation of the long noncoding RNA FOXD2-AS1
predicts poor prognosis in esophageal squamous cell carcinoma.
Cancer Biomark. 21:527–533. 2018. View Article : Google Scholar
|
|
41
|
Sadeghpour S and Ghorbian S: Evaluation of
the potential clinical prognostic value of lncRNA-BANCR gene in
esophageal squamous cell carcinoma. Mol Biol Rep. 46:991–995. 2019.
View Article : Google Scholar
|
|
42
|
He A, Liu Y, Chen Z, Li J, Chen M, Liu L,
Liao X, Lv Z, Zhan Y, Zhuang C, et al: Over-expression of long
noncoding RNA BANCR inhibits malignant phenotypes of human bladder
cancer. J Exp Clin Cancer Res. 35:1252016. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Yang L and Liu G: lncRNA BANCR suppresses
cell viability and invasion and promotes apoptosis in
non-small-cell lung cancer cells in vitro and in vivo. Cancer Manag
Res. 11:3565–3574. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Tay Y, Rinn J and Pandolfi PP: The
multilayered complexity of ceRNA crosstalk and competition. Nature.
505:344–352. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Gao H, Gong N, Ma Z, Miao X, Chen J, Cao Y
and Zhang G: lncRNA ZEB2-AS1 promotes pancreatic cancer cell growth
and invasion through regulating the miR-204/HMGB1 axis. Int J Biol
Macromol. 116:545–551. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Guo H, Yang S, Li S, Yan M, Li L and Zhang
H: lncRNA SNHG20 promotes cell proliferation and invasion via
miR-140-5p-ADAM10 axis in cervical cancer. Biomed Pharmacother.
102:749–757. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Heery R, Finn SP, Cuffe S and Gray SG:
Long non-coding RNAs: Key regulators of epithelial-mesenchymal
transition, tumour drug resistance and cancer stem cells. Cancers
(Basel). 9. pp. 382017, View Article : Google Scholar
|
|
48
|
Cao R, Shao J, Hu Y, Wang L, Li Z, Sun G
and Gao X: MicroRNA-338-3p inhibits proliferation, migration,
invasion, and EMT in osteosarcoma cells by targeting activator of
90 kDa heat shock protein ATPase homolog 1. Cancer Cell Int.
18:492018. View Article : Google Scholar
|
|
49
|
Ding Z, Zhu J, Zeng Y, Du W, Zhang Y, Tang
H, Zheng Y, Qin H, Liu Z and Huang JA: The regulation of Neuropilin
1 expression by miR-338-3p promotes non-small cell lung cancer via
changes in EGFR signaling. Mol Carcinog. 58:1019–1032. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Liu S, Suo J, Wang C, Sun X, Wang D, He L,
Zhang Y and Li W: Downregulation of tissue miR-338-3p predicts
unfavorable prognosis of gastric cancer. Cancer Biomark.
21:117–122. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Liu F, Yang X, Geng M and Huang M:
Targeting ERK, an Achilles' Heel of the MAPK pathway, in cancer
therapy. Acta Pharm Sin B. 8:552–562. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Pollak MN, Schernhammer ES and Hankinson
SE: Insulin-like growth factors and neoplasia. Nat Rev Cancer.
4:505–518. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Chen J, Deng T, Li X and Cai W: miR-193b
inhibits the growth and metastasis of renal cell carcinoma by
targeting IGF1R. Artif Cells Nanomed Biotechnol. 47:2058–2064.
2019. View Article : Google Scholar : PubMed/NCBI
|
